Kalaris Therapeutics Filing Effectiveness Noted
Ticker: KLRS · Form: EFFECT · Filed: Apr 14, 2026
Sentiment: neutral
Topics: registration-statement, effectiveness, sec-filing
TL;DR
Kalaris Therapeutics SEC filing EFFECT is now effective as of 4/13/2026. Get ready.
AI Summary
Kalaris Therapeutics, Inc. filed an EFFECT form on April 14, 2026, indicating the effectiveness of a registration statement. The filing, with accession number 9999999995-26-001176, relates to Act 33 and File No. 333-294883. The effectiveness date was April 13, 2026.
Why It Matters
This filing signifies that Kalaris Therapeutics, Inc. has met the necessary SEC requirements for a registration statement to become effective, potentially paving the way for securities offerings.
Risk Assessment
Risk Level: low — This is a procedural filing confirming the effectiveness of a registration statement, not a filing detailing significant financial changes or events.
Key Numbers
- 2026-04-13 — Effectiveness Date (The date the registration statement became effective.)
- 2026-04-14 — Filing Date (The date the SEC accepted the filing.)
Key Players & Entities
- Kalaris Therapeutics, Inc. (company) — Filer
- 9999999995-26-001176 (dollar_amount) — SEC Accession Number
- 2026-04-14 (dollar_amount) — Filing Acceptance Date
- 2026-04-13 (dollar_amount) — Effectiveness Date
- 333-294883 (dollar_amount) — File Number
FAQ
What type of filing is this EFFECT form for Kalaris Therapeutics, Inc.?
This EFFECT form is a Notice of Effectiveness for a registration statement filed by Kalaris Therapeutics, Inc.
What is the SEC accession number for this filing?
The SEC accession number for this filing is 9999999995-26-001176.
When did the registration statement filed by Kalaris Therapeutics, Inc. become effective?
The registration statement became effective on April 13, 2026.
What is the CIK number for Kalaris Therapeutics, Inc.?
The CIK number for Kalaris Therapeutics, Inc. is 0001754068.
What is the file number associated with this filing?
The file number associated with this filing is 333-294883.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 14, 2026 regarding Kalaris Therapeutics, Inc. (KLRS).